ClinicalTrials.Veeva

Menu

Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP)

NeuroTherapia, Inc. logo

NeuroTherapia, Inc.

Status and phase

Completed
Phase 1

Conditions

Familial Adenomatous Polyposis

Treatments

Drug: Black Raspberry (BRB) Placebo Slurry
Drug: Black raspberry (BRB) Slurry
Drug: Black Raspberry (BRB) Suppositories

Study type

Interventional

Funder types

Other

Identifiers

NCT00770991
2003-34501-13965

Details and patient eligibility

About

This is a 36 week dietary intervention pilot study to evaluate the effects of lyophilized black raspberries on rectal polyp burden and biomarkers in subjects with FAP. Subjects will undergo a colonoscopy or sigmoidoscopy before study treatment to determine eligibility for the study. Eligible participants will undergo a sigmoidoscopy at 36 weeks after the initiation of study treatment. The size and number of rectal polyps will be documented on a code sheet and by photograph. The efficacy outcome will include the percentage reduction in the number of rectal polyps between baseline and 36 weeks.

Enrollment

34 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of familial adenomatous polyposis with at least 5 rectal polyps which are greater than or equal to 2 mm on baseline colonoscopy
  • Have an endoscopically assessable rectal segment
  • Have not taken NSAIDs or selective COX-2 inhibitors for two months prior to the study and willing to remain off NSAIDs for the study duration.

Exclusion criteria

  • Known allergies or hypersensitivity to berries
  • Diabetes mellitus
  • Subjects taking NSAIDs or COX-2 inhibitors who cannot be taken off the medication due to their clinical condition.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

34 participants in 2 patient groups

Black Raspberry (BRB) Slurry plus BRB suppositories
Experimental group
Description:
20 grams BRB Slurry BID plus two, 730 mg BRB suppositories HS
Treatment:
Drug: Black raspberry (BRB) Slurry
Drug: Black Raspberry (BRB) Suppositories
Black Raspberry (BRB) Placebo Slurry plus BRB suppositories
Experimental group
Description:
20 grams BRB Placebo Slurry BID plus two, 730 mg BRB suppositories HS
Treatment:
Drug: Black Raspberry (BRB) Suppositories
Drug: Black Raspberry (BRB) Placebo Slurry

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems